Video

Expert Discusses Limitations and Risks of Integrative Medicine

Author(s):

Ashley Gallagher, Editor
Conference|NANETS Annual Multidisciplinary NET Medical Symposium - North American Neuroendocrine Tumor Society Annual Multidisciplinary NET Medical Symposium

Kaushal Nanavati, MD, assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center discusses what the different kinds or research shows about integrative medicine and the potential risk of this treatment.

In a Pharmacy Times® interview, Kaushal Nanavati, MD, FAAFP, ABOIM, ABIHM assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center, spoke about his 2021 NANETS presentation on the integrative management of neuroendocrine tumors.

He discussed what the different kinds or research shows about integrative medicine and the potential risk of this treatment.

Related Videos
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: Dr_Microbe | stock.adobe.com
Related Content
Molecular biologist holding blood sample for EGFR mutation test for the diagnosis of lung disease. Epidermal Growth Factor Receptor.
June 4th 2025

Neoadjuvant Osimertinib With or Without Chemotherapy Improves Response in Resectable EGFRm NSCLC

Luke Halpern, Assistant Editor
S2. Ep 56: Insights from a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights from a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Chemotherapy IV drip -- Image credit: sweetlemontea | stock.adobe.com
June 4th 2025

ASCO 2025: Adding Carboplatin Did Not Result in Statistically Significant Improvements in Patients With TNBC

Gillian McGovern, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Effects and treatment of statins concept photo. Open packaging with drugs tablets, on which is written "Statin Medication", lies near stethoscope, result analysis on cholesterol (lipid panel) and ECG
June 3rd 2025

Expert Q&A: Pharmacist-Led Strategies to Improve Cholesterol Management

Luke Halpern, Assistant Editor Amanda Gronniger, PharmD, CPh, BCCP
Darolutamide Approved by FDA for Metastatic Castration-Sensitive Prostate Cancer
Published: June 3rd 2025 | Updated: June 3rd 2025

Darolutamide Approved by FDA for Metastatic Castration-Sensitive Prostate Cancer

Luke Halpern, Assistant Editor